Argitalpenak (82) JOAQUIN BELZUNEGUI OTANO argitalpenak

2024

  1. Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 4, pp. 208-214

  2. Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register

    RMD open, Vol. 10, Núm. 1

  3. Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice

    Reumatologia Clinica, Vol. 20, Núm. 1, pp. 24-31

2023

  1. Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of fibroscan and biochemical markers in routine clinical practice

    Reumatologia Clinica, Vol. 19, Núm. 8, pp. 412-416

  2. Coronavirus Disease 2019 in Rheumatic Patientswith Inflammatory Disorders: A Descriptive Study from a High Infection Incidence Region of Northern Spain

    EUROPEAN JOURNAL OF RHEUMATOLOGY, Vol. 10, Núm. 4

  3. Liver steatosis in patients with rheumatoid arthritis treated with methotrexate is associated with body mass index

    World Journal of Hepatology, Vol. 15, Núm. 5, pp. 699-706

  4. Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study

    Rheumatology and Therapy, Vol. 10, Núm. 5, pp. 1319-1333

2022

  1. Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study) (Rheumatology and Therapy, (2022), 9, 2, (589-608), 10.1007/s40744-021-00423-8)

    Rheumatology and Therapy

  2. Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology

    Reumatologia Clinica, Vol. 18, Núm. 5, pp. 253-259

  3. Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study)

    Rheumatology and Therapy, Vol. 9, Núm. 2, pp. 589-608

  4. Treatment Failure in Axial Spondyloarthritis: Insights for a Standardized Definition

    Advances in Therapy, Vol. 39, Núm. 4, pp. 1490-1501

2021

  1. Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial

    Rheumatology and Therapy, Vol. 8, Núm. 3, pp. 1323-1339

  2. Evaluation of the collaboration between Primary and Hospital Care in order to improve inappropriate prescription

    Journal of Healthcare Quality Research, Vol. 36, Núm. 2, pp. 91-97

2020

  1. Digestive involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry

    Clinical and experimental rheumatology, Vol. 38, Núm. 4, pp. 110-115

  2. Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome

    Rheumatology International, Vol. 40, Núm. 8, pp. 1259-1265

2019

  1. ESSDAI activity index of the SJÖGRENSER cohort: analysis and comparison with other European cohorts

    Rheumatology International

  2. LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients

    Rheumatology International, Vol. 39, Núm. 11, pp. 1875-1882

  3. Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial

    Arthritis and Rheumatology, Vol. 71, Núm. 10, pp. 1616-1625

2017

  1. Categorización diagnóstica según los criterios del First International Workshop on Ocular Sarcoidosis (FIWOS) en una serie de 11 pacientes

    Reumatologia Clinica

  2. Desprescripción de tratamientos de larga duración con bisfosfonatos para la osteoporosis en atención primaria en el País Vasco

    Gaceta Sanitaria, Vol. 31, Núm. 1, pp. 35-39